STOCKSCREENR
Log In

MEDP

NASDAQ

Medpace Holdings, Inc.

$455.15+1.51(+0.33%)Mkt Cap: $12.92B

Key Stats

Market Cap

$12.92B

P/E Ratio

29.77

EPS

$15.29

Dividend Yield

0.00%

52-Week Range

$250.05 — $628.92

Volume

326.66K

Avg Volume

327.99K

Beta

1.46

Valuation

P/E (TTM)

29.77

Forward P/E

26.57

PEG Ratio

4.40

P/S (TTM)

5.37

P/B (TTM)

29.49

P/FCF

56.91

EV/EBITDA

98.65x

EV/Sales

—

Financial Health

ROE (TTM)

1.19%

ROA (TTM)

0.23%

ROIC

0.30%

Gross Margin

0.30%

Operating Margin

0.21%

Net Margin

0.17%

Debt/Equity

0.55

Current Ratio

0.74

Growth

EPS Growth (YoY)

+0.23%

Revenue Growth (YoY)

+0.32%

EPS Growth (3Y)

—

EPS Growth (5Y)

—

Sales Growth (3Y)

—

Sales Growth (5Y)

—

EPS Est (This Year)

$17.13

EPS Est (Next Year)

$19.06

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

0.00%

Frequency

—

Ex-Dividend Date

—

Cash/Share

$17.57

Analyst Consensus

4.0

Sell

1 = Strong Buy, 5 = Strong Sell

Price Target Range

$460.00$549.50$582.00
LowMedianHigh

Consensus Target: $534.17(17.4% upside)

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

28.38M

Float

22.84M

Free Float %

80.48%

About

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

US

Exchange

NASDAQ

IPO Date

2016-08-11

Employees

5900

CEO

August James Troendle

Index Membership

—

Website

https://www.medpace.com

Medpace Holdings, Inc. (MEDP) is a healthcare company in the medical - diagnostics & research industry listed on the NASDAQ. With a market capitalization of $12.92B, a P/E ratio of 29.77, MEDP is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare MEDP against other stocks using dozens of fundamental and technical filters.

Similar Stocks

0KHE.L

Revvity, Inc.

$88.87

+3.35%

$9.89B

LH

Labcorp Holdings Inc.

$270.62

+1.41%

$22.43B

ILMN

Illumina, Inc.

$120.84

+1.31%

$18.48B

NTRA

Natera, Inc.

$198.38

+0.35%

$28.12B

RDNT

RadNet, Inc.

$63.63

-0.73%

$4.94B

BLLN

BillionToOne, Inc.

$69.76

-2.21%

$3.20B

Frequently Asked Questions

What is Medpace Holdings, Inc.'s P/E ratio?

Medpace Holdings, Inc. (MEDP) has a trailing twelve-month (TTM) P/E ratio of 29.77. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Medpace Holdings, Inc. pay a dividend?

No, Medpace Holdings, Inc. (MEDP) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Medpace Holdings, Inc.'s market cap?

Medpace Holdings, Inc. (MEDP) has a market capitalization of $12.92 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.

What do analysts think about MEDP?

Wall Street analysts have a consensus "Sell" rating on Medpace Holdings, Inc. (MEDP) with an average score of 4.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $534.17 implies 17.4% upside from the current price.